GMP manufacturing excellence to deliver the optimal dosage form with safety, quality, and regulatory confidence.
GMP manufacturing for complex small molecules—delivering safe, effective, and compliant drug products.
Eurofins CDMO offers GMP-compliant clinical and commercial manufacturing of non-sterile and sterile drug products, including solutions, suspensions, emulsions, SEDDS, semi-solids, capsules, and tablets.
Eurofins CDMO offers integrated non-sterile GMP manufacturing for solid, semi-solid, and liquid drug products, including high-potency and niche programmes. Our capabilities span raw material sourcing to packaging, with advanced technologies like bilayer tablets, nanomilling, minitablets, and conventional processes such as granulation, capsule filling, and tableting.
Our advanced production lines are designed for both liquid and lyophilised forms, catering to various fill volumes and minimising dead volume. We accommodate a broad spectrum of compounds, primary packaging systems, batch sizes and fill volumes, with a further expansion in 2026 to 85,000 unit per day capacity.